N@N

Imaging3, Inc.: WallStreetReporter.com Interviews CEO of Imaging3, Inc.

^{Published on 2009-05-19 12:55:47, Last Modified on 2009-11-02 12:30:49 - Market Wire}
 

BURBANK, CA--(Marketwire - May 19, 2009) - Imaging3™, Inc. (OTCBB: [ IMGG ]) CEO Dean Janes was interviewed by WallStreetReporter.com.

WallStreetReporter.com is a multi-media financial research and publishing company, which reports to the investment community on publicly held companies.

The interview highlighted the company's status as a leader in the development of 3D medical diagnostic imaging technology and its intent to use its existing base of operations and channels of distribution to launch its new medical imaging devices business, based on its breakthrough Imaging3 Technology.

The audio interview was conducted May 14, 2009. The interview is available online via the following link:

[ http://www.wallstreetreporter.com/index.php/2009/05/imaging3-inc-otc-bb-imgg-ceo-interview ]

About Imaging3

Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at [ www.imaging3.com ]

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing